EPSTEIN-BARR-VIRUS RECOMBINANT MOLECULAR-GENETIC ANALYSIS OF THE LMP1AMINO-TERMINAL CYTOPLASMIC DOMAIN REVEALS A PROBABLE STRUCTURAL ROLE,WITH NO COMPONENT ESSENTIAL FOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION
Km. Izumi et al., EPSTEIN-BARR-VIRUS RECOMBINANT MOLECULAR-GENETIC ANALYSIS OF THE LMP1AMINO-TERMINAL CYTOPLASMIC DOMAIN REVEALS A PROBABLE STRUCTURAL ROLE,WITH NO COMPONENT ESSENTIAL FOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION, Journal of virology, 68(7), 1994, pp. 4369-4376
Previous recombinant Epstein-Barr virus molecular genetic experiments
with specifically mutated LMP1 genes indicate that LMP1 is essential f
or primary B-lymphocyte growth transformation and that the amino-termi
nal cytoplasmic and first transmembrane domains are together an import
ant mediator of transformation. EBV recombinants with specific deletio
ns in the amino-terminal cytoplasmic domain have now been constructed
and tested for the ability to growth transform primary B lymphocytes i
nto lymphoblastoid cell lines. Surprisingly, deletion of DNA encoding
EHDLER or GPPLSSS from the full LMP1 amino-terminal cytoplasmic domain
(MEHDLERGPPGPRRPPRGPPLSSS) had no discernible effect on primary B-lym
phocyte transformation. These two motifs distinguish the LMP1 amino-te
rminal cytoplasmic domain from other arginine-rich membrane proximal s
equences that anchor hydrophobic transmembrane domains, Two deletions
which included the ERGPPGPRRPPR motif adversely affected but did not p
revent transformation. This arginine- and proline-rich sequence is pro
bably important in anchoring the first transmembrane domain in the pla
sma membrane, since these mutated LMP1s had altered stability and cell
membrane localization. The finding that overlapping deletions of the
entire amino-terminal cytoplasmic domain do not ablate transformation
is most consistent with a model postulating that the transmembrane and
carboxyl-terminal cytoplasmic domains are the likely biochemical effe
cters of transformation.